PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 2070484
PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 2070484
Cardiovascular Ultrasound Market Size, Share, Growth, Global Industry Analysis, Regional Insights and Forecast to 2026-2034
Growth Factors of cardiovascular ultrasound Market
The global cardiovascular ultrasound market size was valued at USD 2.58 billion in 2025 and is projected to grow from USD 2.74 billion in 2026 to USD 4.33 billion by 2034, exhibiting a CAGR of 5.9% during the forecast period. North America dominated the market with a 33.33% market share in 2025, supported by advanced healthcare infrastructure, strong adoption of diagnostic imaging technologies, and the presence of leading industry participants.
Cardiovascular ultrasound, commonly known as echocardiography, is a non-invasive imaging technology used to assess heart anatomy, blood flow, chamber dimensions, valve performance, and overall cardiac function in real time. Growing prevalence of cardiovascular diseases, increasing need for early diagnosis, and rising demand for point-of-care imaging solutions are driving market expansion worldwide.
Leading companies such as GE HealthCare, Koninklijke Philips N.V., and Siemens Healthineers maintained a dominant market position in 2025 due to their extensive cardiovascular imaging portfolios, technological innovations, and broad global distribution networks.
Cardiovascular Ultrasound Market Trends
AI-Driven Automation Emerging as a Key Market Trend
Artificial intelligence is transforming cardiovascular ultrasound by improving workflow efficiency, reducing examination time, and enhancing diagnostic accuracy. Manufacturers are increasingly integrating AI-powered tools that automate image acquisition, measurement, quantification, and reporting processes.
In June 2024, Koninklijke Philips N.V. introduced FDA-cleared AI applications for its EPIQ CVx and Affiniti CVx systems, including automated wall motion scoring and 3D quantification of mitral regurgitation. Such innovations are helping healthcare providers improve productivity while delivering more consistent diagnostic outcomes.
Market Drivers
Rising Cardiovascular Disease Burden Fueling Demand
The growing incidence of cardiovascular disorders remains the primary growth driver for the market. According to the Journal of the American College of Cardiology (JACC), approximately 315 million people were living with coronary artery disease in 2022. The increasing patient population requires frequent diagnostic imaging, follow-up monitoring, and procedural guidance.
Cardiovascular ultrasound remains one of the most preferred diagnostic modalities due to its non-invasive nature, affordability, portability, and ability to provide real-time imaging. These advantages continue to support widespread adoption across hospitals, outpatient centers, and emergency care settings.
Market Restraints
Dependence on Skilled Professionals Limiting Adoption
Despite technological advancements, cardiovascular ultrasound examinations require trained sonographers and cardiologists for accurate image acquisition and interpretation. Shortages of qualified healthcare professionals continue to challenge market growth.
According to the Radiological Society of North America (RSNA), physician shortages could range from 37,800 to 124,000 professionals by 2034, potentially impacting imaging service availability and limiting adoption rates in several regions.
Market Opportunities
Handheld Ultrasound and AI Integration Creating Growth Potential
The increasing adoption of handheld ultrasound devices and AI-assisted imaging platforms is creating significant growth opportunities. These technologies simplify cardiac assessments and enable non-specialists to obtain diagnostic-quality images.
In April 2024, GE HealthCare launched Caption AI on the Vscan Air SL handheld ultrasound system, enabling real-time probe guidance and automated ejection fraction calculations. Such innovations are expected to expand cardiovascular ultrasound usage in rural healthcare facilities, ambulatory centers, and preventive cardiology programs.
Market Challenges
High Cost of Advanced Imaging Systems
Premium cardiovascular ultrasound systems equipped with AI capabilities, 3D/4D imaging, and advanced visualization technologies require substantial capital investment. Maintenance costs, software upgrades, and user training further increase ownership expenses, creating challenges for healthcare facilities with limited budgets.
Segmentation Analysis
By Product
The systems segment held the largest market share in 2025 due to increasing demand for advanced imaging platforms and expansion of healthcare infrastructure globally.
The accessories & consumables segment is expected to register a CAGR of 7.5% during the forecast period owing to growing procedural volumes and recurring demand for ultrasound consumables.
By Application
The cardiac structure and function assessment segment dominated the market in 2025 and is projected to account for 32.7% of the market in 2026. The segment benefits from widespread use of echocardiography for evaluating ventricular function, chamber dimensions, and cardiac morphology.
The valvular heart disease assessment segment is anticipated to grow at a CAGR of 6.1% through 2034.
By End User
Hospitals & ASCs accounted for the largest share in 2025 and are projected to represent 65.3% of the market in 2026. Growth is driven by increasing patient admissions, complex cardiac procedures, and rising demand for perioperative imaging.
The specialty clinics segment is forecast to expand at a CAGR of 7.1% during the study period.
Regional Analysis
North America
North America generated USD 0.86 billion in 2025, making it the largest regional market. Strong healthcare spending, advanced diagnostic infrastructure, and rapid adoption of innovative ultrasound technologies support regional dominance.
The U.S. cardiovascular ultrasound market is expected to reach USD 0.80 billion in 2026, representing approximately 29.2% of global revenue.
Europe
Europe is projected to grow at a 5.3% CAGR during the forecast period and reach USD 0.72 billion in 2026. Growth is supported by a strong network of hospitals, diagnostic imaging centers, and trained radiology professionals.
Germany is expected to reach USD 0.15 billion in 2026, while the U.K. market is projected to attain USD 0.12 billion.
Asia Pacific
Asia Pacific is anticipated to become the second-largest regional market, reaching approximately USD 0.80 billion in 2026. Rising cardiovascular disease prevalence, healthcare infrastructure development, and increasing investments in diagnostic imaging are driving regional growth.
China is projected to generate USD 0.28 billion, Japan USD 0.15 billion, and India USD 0.11 billion in 2026.
Latin America and Middle East & Africa
These regions are expected to witness steady growth due to improving healthcare accessibility and increasing awareness regarding early cardiovascular disease diagnosis. Latin America is projected to reach USD 0.19 billion by 2026, while the GCC market is estimated at USD 0.05 billion.
Competitive Landscape
The cardiovascular ultrasound market remains highly competitive, led by GE HealthCare, Koninklijke Philips N.V., Siemens Healthineers, Canon Medical Systems Corporation, FUJIFILM Holdings Corporation, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Esaote SPA, SonoScape Medical Corp, Butterfly Network, Inc., and Konica Minolta, Inc.
Major companies are focusing on AI-enabled imaging platforms, product launches, strategic collaborations, acquisitions, and geographic expansion to strengthen their market positions.
Key Industry Developments
- August 2025: Philips launched Transcend Plus for EPIQ CVx and Affiniti CVx with enhanced AI capabilities.
- March 2025: FUJIFILM partnered with Us2.ai to integrate AI-driven echocardiography analysis into LISENDO workflows.
- August 2024: Siemens Healthineers received FDA clearance for ACUSON Origin and AcuNav Lumos 4D ICE catheter.
- June 2024: Philips introduced next-generation AI-enabled cardiovascular ultrasound solutions.
- April 2024: FUJIFILM launched the OPIE transducer for intracardiac echocardiography imaging.
- January 2024: Butterfly Network received FDA clearance for Butterfly iQ3 handheld ultrasound.
- October 2023: GE HealthCare launched Caption AI on the Vscan Air SL platform.
Conclusion
The cardiovascular ultrasound market is poised for steady expansion, growing from USD 2.58 billion in 2025 to USD 2.74 billion in 2026 and reaching USD 4.33 billion by 2034. Rising cardiovascular disease prevalence, growing adoption of AI-powered imaging solutions, increasing utilization of handheld ultrasound devices, and expanding healthcare infrastructure are expected to drive market growth. Although challenges such as skilled workforce shortages and high equipment costs persist, continuous technological innovation and broader access to advanced diagnostic imaging are likely to create significant opportunities for industry participants throughout the forecast period.
Segmentation By Product, Application, End-user, and Region
By Product * Systems
- Accessories & Consumables
By Application * Cardiac Structure and Function Assessment
- Valvular Heart Disease Assessment
- Heart Failure and Cardiomyopathy Evaluation
- Coronary and Vascular Imaging Guidance
- Congenital Heart Disease Assessment
- Others
By End-user * Hospitals & ASCs
- Specialty Clinics
- Diagnostic Imaging Centers
- Others
By Region * North America (By Product, Application, End-user, and Country)
- U.S. (By Product)
- Canada (By Product)
- Europe (By Product, Application, End-user, and Country/Sub-region)
- Germany (By Product)
- U.K. (By Product)
- France (By Product)
- Spain (By Product)
- Italy (By Product)
- Scandinavia (By Product)
- Rest of Europe (By Product)
- Asia Pacific (By Product, Application, End-user, and Country/Sub-region)
- China (By Product)
- Japan (By Product)
- India (By Product)
- Australia (By Product)
- Southeast Asia (By Product)
- Rest of Asia Pacific (By Product)
- Latin America (By Size, Procedure, End-user, and Country/Sub-region)
- Brazil (By Product)
- Mexico (By Product)
- Rest of Latin America (By Product)
- Middle East & Africa (By Product, Application, End-user, and Country/Sub-region)
- GCC (By Product)
- South Africa (By Product)
- Rest of the Middle East & Africa (By Product)
Table of Content
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
- 3.4. Market Trends
4. Key Insights
- 4.1. Prevalence of Key Conditions, by key Country/Region, 2025
- 4.2. Advancements in Cardiovascular Ultrasound
- 4.3. Key Industry Developments - (Mergers, Acquisitions & Partnerships, etc.)
5. Global Cardiovascular Ultrasound Market Analysis, Insights and Forecast, 2021-2034
- 5.1. Market Analysis, Insights and Forecast - By Product
- 5.1.1. Systems
- 5.1.2. Accessories & Consumables
- 5.2. Market Analysis, Insights and Forecast - By Application
- 5.2.1. Cardiac Structure and Function Assessment
- 5.2.2. Valvular Heart Disease Assessment
- 5.2.3. Heart Failure and Cardiomyopathy Evaluation
- 5.2.4. Coronary and Vascular Imaging Guidance
- 5.2.5. Congenital Heart Disease Assessment
- 5.2.6. Others
- 5.3. Market Analysis, Insights and Forecast - By End-user
- 5.3.1. Hospitals & ASCs
- 5.3.2. Specialty Clinics
- 5.3.3. Diagnostic Imaging Centers
- 5.3.4. Others
- 5.4. Market Analysis, Insights and Forecast - By Region
- 5.4.1. North America
- 5.4.2. Europe
- 5.4.3. Asia Pacific
- 5.4.4. Latin America
- 5.4.5. Middle East & Africa
6. North America Cardiovascular Ultrasound Market Analysis, Insights and Forecast, 2021-2034
- 6.1. Market Analysis, Insights and Forecast - By Product
- 6.1.1. Systems
- 6.1.2. Accessories & Consumables
- 6.2. Market Analysis, Insights and Forecast - By Application
- 6.2.1. Cardiac Structure and Function Assessment
- 6.2.2. Valvular Heart Disease Assessment
- 6.2.3. Heart Failure and Cardiomyopathy Evaluation
- 6.2.4. Coronary and Vascular Imaging Guidance
- 6.2.5. Congenital Heart Disease Assessment
- 6.2.6. Others
- 6.3. Market Analysis, Insights and Forecast - By End-user
- 6.3.1. Hospitals & ASCs
- 6.3.2. Specialty Clinics
- 6.3.3. Diagnostic Imaging Centers
- 6.3.4. Others
- 6.4. Market Analysis, Insights and Forecast - By Country
- 6.4.1. U.S.
- 6.4.1.1. By Product
- 6.4.2. Canada
- 6.4.2.1. By Product
- 6.4.1. U.S.
7. Europe Cardiovascular Ultrasound Market Analysis, Insights and Forecast, 2021-2034
- 7.1. Market Analysis, Insights and Forecast - By Product
- 7.1.1. Systems
- 7.1.2. Accessories & Consumables
- 7.2. Market Analysis, Insights and Forecast - By Application
- 7.2.1. Cardiac Structure and Function Assessment
- 7.2.2. Valvular Heart Disease Assessment
- 7.2.3. Heart Failure and Cardiomyopathy Evaluation
- 7.2.4. Coronary and Vascular Imaging Guidance
- 7.2.5. Congenital Heart Disease Assessment
- 7.2.6. Others
- 7.3. Market Analysis, Insights and Forecast - By End-user
- 7.3.1. Hospitals & ASCs
- 7.3.2. Specialty Clinics
- 7.3.3. Diagnostic Imaging Centers
- 7.3.4. Others
- 7.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
- 7.4.1. Germany
- 7.4.1.1. By Product
- 7.4.2. U.K.
- 7.4.2.1. By Product
- 7.4.3. France
- 7.4.3.1. By Product
- 7.4.4. Italy
- 7.4.4.1. By Product
- 7.4.5. Spain
- 7.4.5.1. By Product
- 7.4.6. Scandinavia
- 7.4.6.1. By Product
- 7.4.7. Rest of Europe
- 7.4.7.1. By Product
- 7.4.1. Germany
8. Asia Pacific Cardiovascular Ultrasound Market Analysis, Insights and Forecast, 2021-2034
- 8.1. Market Analysis, Insights and Forecast - By Product
- 8.1.1. Systems
- 8.1.2. Accessories & Consumables
- 8.2. Market Analysis, Insights and Forecast - By Application
- 8.2.1. Cardiac Structure and Function Assessment
- 8.2.2. Valvular Heart Disease Assessment
- 8.2.3. Heart Failure and Cardiomyopathy Evaluation
- 8.2.4. Coronary and Vascular Imaging Guidance
- 8.2.5. Congenital Heart Disease Assessment
- 8.2.6. Others
- 8.3. Market Analysis, Insights and Forecast - By End-user
- 8.3.1. Hospitals & ASCs
- 8.3.2. Specialty Clinics
- 8.3.3. Diagnostic Imaging Centers
- 8.3.4. Others
- 8.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
- 8.4.1. China
- 8.4.1.1. By Product
- 8.4.2. India
- 8.4.2.1. By Product
- 8.4.3. Japan
- 8.4.3.1. By Product
- 8.4.4. Australia
- 8.4.4.1. By Product
- 8.4.5. Southeast Asia
- 8.4.5.1. By Product
- 8.4.6. Rest of Asia Pacific
- 8.4.6.1. By Product
- 8.4.1. China
9. Latin America Cardiovascular Ultrasound Market Analysis, Insights and Forecast, 2021-2034
- 9.1. Market Analysis, Insights and Forecast - By Product
- 9.1.1. Systems
- 9.1.2. Accessories & Consumables
- 9.2. Market Analysis, Insights and Forecast - By Application
- 9.2.1. Cardiac Structure and Function Assessment
- 9.2.2. Valvular Heart Disease Assessment
- 9.2.3. Heart Failure and Cardiomyopathy Evaluation
- 9.2.4. Coronary and Vascular Imaging Guidance
- 9.2.5. Congenital Heart Disease Assessment
- 9.2.6. Others
- 9.3. Market Analysis, Insights and Forecast - By End-user
- 9.3.1. Hospitals & ASCs
- 9.3.2. Specialty Clinics
- 9.3.3. Diagnostic Imaging Centers
- 9.3.4. Others
- 9.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
- 9.4.1. Brazil
- 9.4.1.1. By Product
- 9.4.2. Mexico
- 9.4.2.1. By Product
- 9.4.3. Rest of Latin America
- 9.4.3.1. By Product
- 9.4.1. Brazil
10. Middle East & Africa Cardiovascular Ultrasound Market Analysis, Insights and Forecast, 2021-2034
- 10.1. Market Analysis, Insights and Forecast - By Product
- 10.1.1. Systems
- 10.1.2. Accessories & Consumables
- 10.2. Market Analysis, Insights and Forecast - By Application
- 10.2.1. Cardiac Structure and Function Assessment
- 10.2.2. Valvular Heart Disease Assessment
- 10.2.3. Heart Failure and Cardiomyopathy Evaluation
- 10.2.4. Coronary and Vascular Imaging Guidance
- 10.2.5. Congenital Heart Disease Assessment
- 10.2.6. Others
- 10.3. Market Analysis, Insights and Forecast - By End-user
- 10.3.1. Hospitals & ASCs
- 10.3.2. Specialty Clinics
- 10.3.3. Diagnostic Imaging Centers
- 10.3.4. Others
- 10.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
- 10.4.1. South Africa
- 10.4.1.1. By Product
- 10.4.2. GCC
- 10.4.2.1. By Product
- 10.4.3. Rest of Middle East & Africa
- 10.4.3.1. By Product
- 10.4.1. South Africa
11. Competitive Analysis
- 11.1. Global Market Share Analysis (2025)
- 11.2. Company Profiles
- 11.2.1. GE HealthCare
- 11.2.2. Koninklijke Philips N.V.
- 11.2.3. Siemens Healthineers
- 11.2.4. Canon Medical Systems Corporation
- 11.2.5. Fujifilm Holdings Corporation
- 11.2.6. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
- 11.2.7. Esaote SPA
- 11.2.8. SonoScape Medical Corp
- 11.2.9. Butterfly Network, inc
- 11.2.10. Konica Minolta, Inc.
List of Tables
- Figure 1: Global Cardiovascular Ultrasound Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
- Figure 2: Global Cardiovascular Ultrasound Market Value Share (%), by Product, 2025 & 2034
- Figure 3: Global Cardiovascular Ultrasound Market Value Share (%), by Application, 2025 & 2034
- Figure 4: Global Cardiovascular Ultrasound Market Value Share (%), by End-user, 2025 & 2034
- Figure 5: Global Cardiovascular Ultrasound Market Value (USD billion), by Region, 2025 & 2034
- Figure 6: North America Cardiovascular Ultrasound Market Value (USD billion), by Product, 2025 & 2034
- Figure 7: North America Cardiovascular Ultrasound Market Value Share (%), by Product, 2025
- Figure 8: North America Cardiovascular Ultrasound Market Value (USD billion), by Application, 2025 & 2034
- Figure 9: North America Cardiovascular Ultrasound Market Value Share (%), by Application, 2025
- Figure 10: North America Cardiovascular Ultrasound Market Value (USD billion), by End-user, 2025 & 2034
- Figure 11: North America Cardiovascular Ultrasound Market Value Share (%), by End-user, 2025
- Figure 12: North America Cardiovascular Ultrasound Market Value (USD billion), By Country, 2025 & 2034
- Figure 13: North America Cardiovascular Ultrasound Market Value Share (%), By Country, 2025
- Figure 14: Europe Cardiovascular Ultrasound Market Value (USD billion), by Product, 2025 & 2034
- Figure 15: Europe Cardiovascular Ultrasound Market Value Share (%), by Product, 2025
- Figure 16: Europe Cardiovascular Ultrasound Market Value (USD billion), by Application, 2025 & 2034
- Figure 17: Europe Cardiovascular Ultrasound Market Value Share (%), by Application, 2025
- Figure 18: Europe Cardiovascular Ultrasound Market Value (USD billion), by End-user, 2025 & 2034
- Figure 19: Europe Cardiovascular Ultrasound Market Value Share (%), by End-user, 2025
- Figure 20: Europe Cardiovascular Ultrasound Market Value (USD billion), By Country/Sub-region, 2025 & 2034
- Figure 21: Europe Cardiovascular Ultrasound Market Value Share (%), By Country/Sub-region, 2025
- Figure 22: Asia Pacific Cardiovascular Ultrasound Market Value (USD billion), by Product, 2025 & 2034
- Figure 23: Asia Pacific Cardiovascular Ultrasound Market Value Share (%), by Product, 2025
- Figure 24: Asia Pacific Cardiovascular Ultrasound Market Value (USD billion), by Application, 2025 & 2034
- Figure 25: Asia Pacific Cardiovascular Ultrasound Market Value Share (%), by Application, 2025
- Figure 26: Asia Pacific Cardiovascular Ultrasound Market Value (USD billion), by End-user, 2025 & 2034
- Figure 27: Asia Pacific Cardiovascular Ultrasound Market Value Share (%), by End-user, 2025
- Figure 28: Asia Pacific Cardiovascular Ultrasound Market Value (USD billion), By Country/Sub-region, 2025 & 2034
- Figure 29: Asia Pacific Cardiovascular Ultrasound Market Value Share (%), By Country/Sub-region, 2025
- Figure 30: Latin America Cardiovascular Ultrasound Market Value (USD billion), by Product, 2025 & 2034
- Figure 31: Latin America Cardiovascular Ultrasound Market Value Share (%), by Product, 2025
- Figure 32: Latin America Cardiovascular Ultrasound Market Value (USD billion), by Application, 2025 & 2034
- Figure 33: Latin America Cardiovascular Ultrasound Market Value Share (%), by Application, 2025
- Figure 34: Latin America Cardiovascular Ultrasound Market Value (USD billion), by End-user, 2025 & 2034
- Figure 35: Latin America Cardiovascular Ultrasound Market Value Share (%), by End-user, 2025
- Figure 36: Latin America Cardiovascular Ultrasound Market Value (USD billion), By Country/Sub-region, 2025 & 2034
- Figure 37: Latin America Cardiovascular Ultrasound Market Value Share (%), By Country/Sub-region, 2025
- Figure 38: Middle East & Africa Cardiovascular Ultrasound Market Value (USD billion), by Product, 2025 & 2034
- Figure 39: Middle East & Africa Cardiovascular Ultrasound Market Value Share (%), by Product, 2025
- Figure 40: Middle East & Africa Cardiovascular Ultrasound Market Value (USD billion), by Application, 2025 & 2034
- Figure 41: Middle East & Africa Cardiovascular Ultrasound Market Value Share (%), by Application, 2025
- Figure 42: Middle East & Africa Cardiovascular Ultrasound Market Value (USD billion), by End-user, 2025 & 2034
- Figure 43: Middle East & Africa Cardiovascular Ultrasound Market Value Share (%), by End-user, 2025
- Figure 44: Middle East & Africa Cardiovascular Ultrasound Market Value (USD billion), By Country/Sub-region, 2025 & 2034
- Figure 45: Middle East & Africa Cardiovascular Ultrasound Market Value Share (%), By Country/Sub-region, 2025
- Figure 46: Global Cardiovascular Ultrasound Market Share (%), By Company, 2025
